Mode
Text Size
Log in / Sign up
Phase 2 Completed N=123 Randomized Prevention

Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery

Kidney Failure, Acute · Renal Replacement Therapy
Source: ClinicalTrials.gov NCT00484354 ↗
Enrolled (actual)
123
Serious AEs
15.8%
Results posted
Oct 2018
Primary outcomePrimary: Number of Participants Who Developed Acute Kidney Injury Within 72 Hours — 17; 14 Participants

Summary

The purpose of this study is to determine if the incidence of acute renal failure (ARF) in high risk patients who undergo coronary artery bypass grafting (CABG) is reduced by treating patients in the perioperative period with intravenous (IV) sodium bicarbonate. Patients will be randomized in a 50:50 allocation to receive either IV sodium bicarbonate or IV normal saline. The volume of fluid given in each arm of the study is equal. All other interventions in those patients will be according to standard cardiothoracic anesthesia protocol at our institution.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Who Developed Acute Kidney Injury Within 72 Hours
17; 14
SECONDARY
Change in GFR Over 72 Hours Post Operatively
21; 21
SECONDARY
Length of Hospital Stay
14.2; 14.6
SECONDARY
Number of Participants With Need for Dialysis
4; 5
SECONDARY
Mortality
9; 10

Eligibility Criteria

Inclusion Criteria

  • Calculated GFR ≤ 60 ml/min/m2 (MDRD)

OR

  • Any combination of two (2) of the following:
  • Age ≥ 70
  • Complex surgery (any of the following):
  • CABG/Valve
  • Redo operation
  • Deep hypothermic arrest
  • ≥ 2 valves
  • History of PVD surgery
  • EF < 35%
  • Presence of diabetes mellitus
  • Prior kidney transplant

Exclusion Criteria

  • Age < 18
  • Pre-existing ESRD (dialysis patients)
  • Pre-op GFR ≤ 15 ml/min/m2
  • Pre-op bicarbonate level ≥ 30 mEq/L
  • Emergency surgery (unable to effectively consent)
  • Pregnancy
  • Heart transplant (OHT)
  • Aortic surgery (proximal or distal)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00484354). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search